期刊文献+

孟鲁司特钠致血尿1例 被引量:9

原文传递
导出
摘要 1临床资料患者女,58岁,因过敏性鼻炎及流涕2012年10月5日来我院耳鼻喉科就诊,给予孟鲁司特钠(杭州默沙东,批号110705)10 mg,qn。服药3 d后出现咖啡色全程血尿,无腰痛、发热症状,遂来我院就诊,腹部B超显示双肾、输尿管、膀胱未见明显异常,尿液及沉渣检查:pH值7.5,蛋白质(-),
作者 谢建翔
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第13期1114-1114,共1页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献11

  • 1Esteitie R,deTineo M,Naclerio RM,etal. Effect of the additionof montelukast to fluticasone propionate for the treatment ofperennial allergic rhinitis [J]. Ann Allergy Asthma Immunol,2010,105(2):155-161.
  • 2Wallerstedt SM. Brunlof G, Sundstrom het al. Montelukastand psychiatric disorders in children [J J. PharmacoepidemiolDrug Saf,2009,18(9):858-864.
  • 3侯会玲.孟鲁司特钠片致皮疹[J].药物不良反应杂志,2008,10(3):183-183. 被引量:11
  • 4李金龙,杨根夫.孟鲁司特钠致排尿困难1例[J].中国现代应用药学,2008,25(2):98-98. 被引量:13
  • 5Castanedo-Tardan MP,Gonzalez ME. Connelly EA, et al. Sys-tematized contact dermatitis and montelukast in an atopic boy[J]. Pediatr Dermatol, 2009,26(6) : 739-743.
  • 6Harugeri A,Parthasarathi G, Sharma J, et al. Montelukast in-duced acute hepatocellular liver injury [J]. J Postgrad Med,2009,55C2):141-142.
  • 7Schumock GT,Gibbons RD, Lee TA. et al. Relationship be-tween leukotriene-modifying agent prescriptions dispensed andrate of suicide deaths by county in the US[J]. Drug HealthcPatient Saf,2011,3:47-52.
  • 8Kanda T,Tanio H, Wu C, et al. Churg-Strauss syndrome withsevere granulomatous angiitis and crescentic glomerulonephri-tis, which developed during therapy with a leukotriene receptorantagonist [J]. Clin Exp Nephrol, 2010,14(6) : 602-607.
  • 9Bibby S, Healy B, Steele R,et al. Association between leukot-riene receptor antagonist therapy and Churg Strauss syndrome:an analysis of the FDA AERS database [J]. Thorax, 2010, 65(2):132-138.
  • 10McDanel DL, Muller BA. The linkage between Churg Strausssyndrome and leukotriene receptor antagonists: fact or fiction[J]. Ther Clin Risk Manag,2005,1 (2) : 125-140.

二级参考文献3

  • 1Calhoun W J, Nelson HS, Nathan RA, et al. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on shortacting beta (2) -agonists alone [ J ], Am J Respir Crit Care Med, 2001, 164 (5): 759-763.
  • 2Dellaripa PF, Wechsler ME, Roth ME, et al. Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents [ J]. Mayo Clin Proc, 2000, 75(6) : 643-645.
  • 3Minciullo PL, Saija A, Bonanno D, et al. Montelukastinduced generalized urticaria [ J ]. Ann Pharmacother, 2004, 38(6): 999-1001.

共引文献15

同被引文献77

  • 1柯长春.孟鲁司特钠致抽搐1例[J].医学信息(医学与计算机应用),2014,0(3):472-472. 被引量:2
  • 2曹玲,陈育智.孟鲁司特治疗儿童哮喘的有效性及安全性观察[J].中华微生物学和免疫学杂志,2001,21(S2):65-67. 被引量:22
  • 3陈金月,茹爱珍.患儿遗尿与孟鲁司特钠咀嚼片有关[J].药物不良反应杂志,2007,9(3):157-157. 被引量:14
  • 4任海军.美药管局:"顺尔宁"等哮喘药可能引发精神问题[N].新华每日电讯(科技·健康),2009-06-16(第007版).
  • 5吴瑞萍,胡亚美,江载芳,等.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:1174-1175
  • 6Esteitie R,deTineo M,Naclerio RM,et al.Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis[J].Ann Allergy Asthma Immunol,2010,(105):155-161.
  • 7O'Byrne PM.Leukotriene bronchoconstriction induced by allergen and exercise[J].Am J Respir Crit Care Med,2000,619 (2):68-72.
  • 8吴天桂.儿童喘息性支气管肺炎及支气管哮喘的预防效果研究[J].求是问药,2012,10(9):652.
  • 9国家药品不良反应监测中心.加拿大警示孟鲁司特钠导致的精神科不良反应[EB/OL].药物警戒快讯.[2010-05-01].http://www.cdr.gov.cn.
  • 10Kanda T,Tanio H,Wu C,Churg-Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis,which developed during therapy with a leukotriene receptor antagonist[J].Clin Exp Nephrol,2010,14(6):602-607.

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部